No takes yet. Share an insight, caveat, or question.
Review describes the contribution of genetic variation to variable cardiovascular drug responses, highlighting mechanisms to guide personalized pharmacotherapy.
Roden et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: